Literature DB >> 18097050

TLR3 increases disease morbidity and mortality from vaccinia infection.

Martha Hutchens1, Kathryn E Luker, Peter Sottile, Joanne Sonstein, Nicholas W Lukacs, Gabriel Núñez, Jeffrey L Curtis, Gary D Luker.   

Abstract

Innate immunity is required for effective control of poxvirus infections, but cellular receptors that initiate the host response to these DNA viruses remain poorly defined. Given this information and the fact that functions of TLRs in immunity to DNA viruses remain controversial, we investigated effects of TLR3 on pathogenesis of vaccinia virus, a prototype poxvirus. We used a recombinant strain Western Reserve vaccinia virus that expresses firefly luciferase to infect wild-type C57BL/6 and TLR3-/- mice through intranasal inoculation. Bioluminescence imaging showed that TLR3-/- mice had substantially lower viral replication in the respiratory tract and diminished dissemination of virus to abdominal organs. Mice lacking TLR3 had reduced disease morbidity, as measured by decreased weight loss and hypothermia after infection. Importantly, TLR3-/- mice also had improved survival relative to wild-type mice. Infected TLR3-/- mice had significantly reduced lung inflammation and recruitment of leukocytes to the lung. Mice lacking TLR3 also had lower levels of inflammatory cytokines, including IL-6, MCP-1, and TNF-alpha in serum and/or bronchoalveolar lavage fluid, but levels of IFN-beta did not differ between genotypes of mice. To our knowledge, our findings show for the first time that interactions between TLR3 and vaccinia increase viral replication and contribute to detrimental effects of the host immune response to poxviruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097050      PMCID: PMC4470388          DOI: 10.4049/jimmunol.180.1.483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo.

Authors:  S K Sambhi; M R Kohonen-Corish; I A Ramshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization.

Authors:  Michael T Rock; Sandra M Yoder; Peter F Wright; Thomas R Talbot; Kathryn M Edwards; James E Crowe
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

3.  Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.

Authors:  Florian Heil; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Carsten Kirschning; Shizuo Akira; Grayson Lipford; Hermann Wagner; Stefan Bauer
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

4.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.

Authors:  Evelyn A Kurt-Jones; Melvin Chan; Shenghua Zhou; Jennifer Wang; George Reed; Roderick Bronson; Michelle M Arnold; David M Knipe; Robert W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

5.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

6.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.

Authors:  Michael D Howell; Richard L Gallo; Mark Boguniewicz; James F Jones; Cathy Wong; Joanne E Streib; Donald Y M Leung
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

7.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.

Authors:  Ronan Le Goffic; Viviane Balloy; Micheline Lagranderie; Lena Alexopoulou; Nicolas Escriou; Richard Flavell; Michel Chignard; Mustapha Si-Tahar
Journal:  PLoS Pathog       Date:  2006-06-09       Impact factor: 6.823

9.  Murine alveolar macrophages limit replication of vaccinia virus.

Authors:  Rachel Rivera; Martha Hutchens; Kathryn E Luker; Joanne Sonstein; Jeffrey L Curtis; Gary D Luker
Journal:  Virology       Date:  2007-02-27       Impact factor: 3.616

10.  Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.

Authors:  Samantha Cooray; Mohammad W Bahar; Nicola G A Abrescia; Colin E McVey; Nathan W Bartlett; Ron A-J Chen; David I Stuart; Jonathan M Grimes; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more
  46 in total

Review 1.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Characterization of equine and other vertebrate TLR3, TLR7, and TLR8 genes.

Authors:  Natalia M Astakhova; Andrey A Perelygin; Andrey A Zharkikh; Teri L Lear; Stephen J Coleman; James N MacLeod; Margo A Brinton
Journal:  Immunogenetics       Date:  2009-07-01       Impact factor: 2.846

3.  Poxvirus Protein MC132 from Molluscum Contagiosum Virus Inhibits NF-B Activation by Targeting p65 for Degradation.

Authors:  Gareth Brady; Darya A Haas; Paul J Farrell; Andreas Pichlmair; Andrew G Bowie
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

Review 4.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

5.  High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors.

Authors:  Jianzhong Zhu; Kevin Smith; Paishiun N Hsieh; Yvonne K Mburu; Saurabh Chattopadhyay; Ganes C Sen; Saumendra N Sarkar
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

Review 6.  Epigenetics and innate immunity: the 'unTolld' story.

Authors:  Conor Hennessy; Declan P McKernan
Journal:  Immunol Cell Biol       Date:  2016-02-29       Impact factor: 5.126

7.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

8.  Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

Authors:  Georges Abboud; Vikas Tahiliani; Pritesh Desai; Kyle Varkoly; John Driver; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

9.  Molluscum Contagiosum Virus Protein MC005 Inhibits NF-κB Activation by Targeting NEMO-Regulated IκB Kinase Activation.

Authors:  Gareth Brady; Darya A Haas; Paul J Farrell; Andreas Pichlmair; Andrew G Bowie
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

10.  Tissue targeting of anti-RNP autoimmunity: effects of T cells and myeloid dendritic cells in a murine model.

Authors:  Eric L Greidinger; Yunjuan Zang; Irina Fernandez; Mariana Berho; Mehdi Nassiri; Laisel Martinez; Robert W Hoffman
Journal:  Arthritis Rheum       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.